Skip to main content
. 2021 Dec 14;13(24):6265. doi: 10.3390/cancers13246265

Figure 1.

Figure 1

Clinical response of a neuroblastoma patient to 3F8 plus yeast beta-glucan. 123MIBG scans before the start of 3F8 plus yeast β-glucan (A) and after (B) 4 cycles of 3F8 plus yeast β-glucan. The skeletal uptake of 123MIBG (seen in skull, appendicular skeleton, pelvis and vertebrae) resolved after treatment with 3F8 plus yeast BG.